title: Are your COPD patients benefiting from best practices?
authors.affiliation: Lynchburg Family Medicine Residency, Lynchburg, VA 48104-1213, USA. deangianakos@yahoo.com
authors.forename: Dean
authors.initials: D
authors.lastname: Gianakos
authors.forename: Rafal
authors.initials: R
authors.lastname: Kaczynski
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019985:Benchmarking / Q000379:methods*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D005194:Family Practice / Q000379:methods; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D012107:Research Design; D012307:Risk Factors; D016540:Smoking Cessation; D013147:Spirometry; D019896:alpha 1-Antitrypsin Deficiency / Q000150:complications / Q000175:diagnosis / Q000628:therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists